Transitional Research Planning

The rapid pace of medical research in a highly competitive environment requires that new developments in the laboratory be carried to the clinic in minimal time. Averion helps clients “translate” scientific discovery into drugs that help patients.  By using in-house expertise and having access to specialized services and therapeutic area thought leaders, we strategize, plan and execute first-in-man trials in order to gain a competitive edge for our sponsors, allowing swift “go/no go” decisions. These services include, but are not limited to:

• Strategic planning and consulting
  • clinical development plans
  • competitive “landscape” assessment
  • regulatory environment evaluation
  • pharmacoeconomic review
• Feasibility,assessment at regional and/or global sites for protocol design, availability of patient populations, investigative site capability
• Project design and management of Phase I/II studies to maximize information and minimize cost and time
• Ancillary service assessments: central and specialized preclinical and clinical laboratory assays, pharmacogenomics and pharmacokinetics
• Pharmacovigilance, medical monitoring and medical writing geared to special needs of first-in-man studies
• Data management focused on  rapid deployment and essential data collection